Interest of systematic screening of pheochromocytoma in patients with neurofibromatosis type 1

Abstract

PHEO in NF1, whether or not secreting, are mostly asymptomatic. The current strategy to explore only symptomatic patients leads to an underestimation of prevalence with the risks inherent to the existence of an unrecognized PHEO.